Odyssey Health, Inc.
ODYY · OTC
7/31/2025 | 7/31/2024 | 7/31/2023 | 7/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.02 | 0.05 | 0.07 | 0.04 |
| FCF Yield | -15.22% | -29.46% | -12.84% | -20.56% |
| EV / EBITDA | -2.85 | -2.70 | -2.58 | -2.25 |
| Quality | ||||
| ROIC | 20.54% | -359.68% | 132.48% | 260.52% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.20 | 1.44 | 0.25 | 0.38 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | -100.00% |
| Free Cash Flow Growth | 71.41% | 18.15% | 53.90% | 5.90% |
| Safety | ||||
| Net Debt / EBITDA | -1.32 | -0.77 | -0.40 | -0.19 |
| Interest Coverage | -4.04 | 27.51 | -8.65 | -9.69 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | -192,079.75 | -238,244.45 |